NN, Inc. Acquires Assets of Bridgemedica, LLC

We represented NN, Inc. (Nasdaq: NNBR) in the acquisition of the assets of Bridgemedica, LLC, a medical device company that provides concept to supply solutions through design, development engineering and manufacturing. Financial terms of the transaction were not publicly disclosed.

NN, Inc., a diversified industrial company combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. NN has 44 manufacturing plants in North America, Western Europe, Eastern Europe, South America and China.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company